Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 84 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 4299. Clear
Clear
Q2
COMMUNITY ONCOLOGY ALLIANCE for COMMUNITY ONCOLOGY ALLIANCE
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Medicare/Medicaid
View →
2A
ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Budget/Appropriations, Health Issues, Medicare/Medicaid
View →
Q2
ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Budget/Appropriations
View →
Q2
ASSOCIATION FOR CLINICAL ONCOLOGY for ASSOCIATION FOR CLINICAL ONCOLOGY
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate
Medicare/Medicaid, Health Issues, Budget/Appropriations
View →
RR
FARRAGUT PARTNERS LLP for TAKEDA PHARMACEUTICALS AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Health Issues
View →
RR
FARRAGUT PARTNERS LLP for SIEMENS HEALTHINEERS
2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia
Health Issues
View →
Q1
AMERICAN COLLEGE OF RHEUMATOLOGY for AMERICAN COLLEGE OF RHEUMATOLOGY
1st Quarter (Jan 1 - Mar 31) 2026 · Georgia · House · Senate
Health Issues, Budget/Appropriations, Medicare/Medicaid
View →
Q1
CENCORA, INC. for CENCORA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Health Issues, Taxation/Internal Revenue Code
View →
Q1
NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMER
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $30,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View →
Q1
AVENUE SOLUTIONS for LARGE UROLOGY GROUP PRACTICE ASSOCIATION (LUGPA)
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
AVENUE SOLUTIONS for GENENTECH USA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS (FORMERLY MCKESSON CORP) for MCKESSON CORPORATION & AFFILIATES U.S. ONCOLOGY AND RX SAVINGS SOLUTIONS
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Manufacturing
View →
Q1
TIBER CREEK GROUP for DAIICHI SANKYO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
THE MCMANUS GROUP for LARGE UROLOGY GROUP PRACTICE ASSOCIATION
1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
THE MCMANUS GROUP for GILEAD SCIENCES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
THE MCMANUS GROUP for GENENTECH
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Health Issues, Taxation/Internal Revenue Code
View →
Q1
TODD STRATEGY GROUP for TAKEDA PHARMACEUTICALS AMERICA, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · $50,000.00 income
Health Issues, Medicare/Medicaid
View →
Q1
JOHNSON & JOHNSON SERVICES, INC. for JOHNSON & JOHNSON SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate
Health Issues, Budget/Appropriations, Copyright/Patent/Trademark, Law Enforcement/Crime/Criminal Justice
View →
Q1
AMGEN, INC. for AMGEN INC
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
STANTON PARK GROUP for MCKESSON CORPATION AND ITS AFFILIATE US ONCOLOGY (FORMERLY US ONCOLOGY)
1st Quarter (Jan 1 - Mar 31) 2026 · Texas · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
ABBVIE, INC. for ABBVIE INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
BRISTOL-MYERS SQUIBB COMPANY for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Copyright/Patent/Trademark
View →
Q1
THE MCMANUS GROUP for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
THE MCMANUS GROUP for INFUSION PROVIDERS ALLIANCE
1st Quarter (Jan 1 - Mar 31) 2026 · Delaware · House · Senate · $90,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
THE MCMANUS GROUP for BRISTOL-MYERS SQUIBB
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $80,000.00 income
Medicare/Medicaid
View →
Page 1 of 4 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem